Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Caccamo

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Immunology|January 15, 2016
Inflammation and the coagulation system in tuberculosis: Tissue Factor leads the danceNadia Caccamo, Francesco Dieli
Cellular & Molecular Immunology|November 26, 2013
Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune systemFrancesco Dieli, Raffaela Fadda, Nadia Caccamo
Current Opinion in Investigational Drugs (London, England : 2000)|September 30, 2008
Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and moreFrancesco Dieli, Nadia Caccamo, Serena Meraviglia
Cellular & Molecular Immunology|January 7, 2022
Spatiotemporal mapping of the leprosy granuloma landscapeMarco P La Manna, Francesco Dieli, Nadia Caccamo
Medicina Nei Secoli|October 27, 2005
[The evolution of didactic programs of Italian medical faculties towards an European standard]Alfredo Salerno, Nadia Caccamo, Serena Meraviglia, et al.
Oncoimmunology|November 19, 2013
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cellsMatilde Todaro, Serena Meraviglia, Nadia Caccamo, et al.
Current Cancer Drug Targets|January 22, 2010
Gammadelta T cell modulation in anticancer treatmentNadia Caccamo, Francesco Dieli, Serena Meraviglia, et al.
British Journal of Haematology|June 2, 2020
Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19Nadia Caccamo, Lucy C Sullivan, Andrew G Brooks, et al.
Journal of Leukocyte Biology|February 8, 2006
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cellsNadia Caccamo, Francesco Dieli, Daniela Wesch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 2, 2010
Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cellsSerena Meraviglia, Nadia Caccamo, Alfredo Salerno, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Immunology|January 15, 2016
Inflammation and the coagulation system in tuberculosis: Tissue Factor leads the danceNadia Caccamo, Francesco Dieli
Cellular & Molecular Immunology|November 26, 2013
Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune systemFrancesco Dieli, Raffaela Fadda, Nadia Caccamo
Current Opinion in Investigational Drugs (London, England : 2000)|September 30, 2008
Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and moreFrancesco Dieli, Nadia Caccamo, Serena Meraviglia
Cellular & Molecular Immunology|January 7, 2022
Spatiotemporal mapping of the leprosy granuloma landscapeMarco P La Manna, Francesco Dieli, Nadia Caccamo
Medicina Nei Secoli|October 27, 2005
[The evolution of didactic programs of Italian medical faculties towards an European standard]Alfredo Salerno, Nadia Caccamo, Serena Meraviglia, et al.
Oncoimmunology|November 19, 2013
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cellsMatilde Todaro, Serena Meraviglia, Nadia Caccamo, et al.
Current Cancer Drug Targets|January 22, 2010
Gammadelta T cell modulation in anticancer treatmentNadia Caccamo, Francesco Dieli, Serena Meraviglia, et al.
British Journal of Haematology|June 2, 2020
Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID-19Nadia Caccamo, Lucy C Sullivan, Andrew G Brooks, et al.
Journal of Leukocyte Biology|February 8, 2006
Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cellsNadia Caccamo, Francesco Dieli, Daniela Wesch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 2, 2010
Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cellsSerena Meraviglia, Nadia Caccamo, Alfredo Salerno, et al.
Pageof 11